Bioventus received ANVISA approval to market DUROLANE® single-injection in Brazil to treat hip osteoarthritis. Pfizer will serve as its exclusive distribution partner.
aap Implantate will receive federal funding in Germany to pursue human clinical study of antibacterial silver coating technology that may inhibit bacterial growth on the surface of an implant.
Vertos Medical enrolled the first patient into MOTION, a new multicenter two-year U.S. study of the mild® outpatient procedure for minimally invasive treatment of lumbar spinal stenosis.
FDA approved an update to the labeling for Zimmer Biomet's Mobi-C® Cervical Disc to include 7-year clinical results, showing the device to be statistically non-inferior in overall study success for 1-level use and statistically superior in overall study success for 2-level use.
The first patient has been treated in a multicenter study comparing Kuros Bioscience's MagnetOs bone graft substitute vs. autologous bone in spinal fusion.